Advertisement VWR acquires United Biochemicals to extend life science capabilities - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

VWR acquires United Biochemicals to extend life science capabilities

US-based VWR International, a provider of laboratory supplies, equipment and services, has acquired United Biochemicals to extend life science capabilities.

United Biochemicals manufactures high purity buffers and biochemicals for research, development and manufacturing processes to biotech, pharmaceutical, cell culture media and medical diagnostic industries.

VWR president and CEO Manuel Brocke-Benz said, "United Biochemicals’ manufacturing expertise, combined with VWR’s existing platform of chemical manufacturing assets, enhances our current offering to our biotech and pharmaceutical customers and strengthens our position in the industry."

Financial details of the transaction remain confidential.

United Biochemicals president Fayyaz Hussain said, "This acquisition will allow United Biochemicals to leverage VWR’s global sales and marketing organization to grow our business."